Anadrol Overview, Dosing & Safety | Peptide Database

Anadrol (Oxymetholone)

Oral Anabolic Steroid | Extreme Mass & Strength

Community Research

Join others researching Anadrol — share findings, ask questions, and learn from real experiences

Anadrol (oxymetholone) is one of the most potent oral anabolic steroids ever developed, originally synthesized in the 1960s by Syntex Pharmaceuticals. It was FDA-approved for the treatment of anemias caused by deficient red blood cell production, including aplastic anemia, myelofibrosis, and anemia associated with chronic kidney disease. Anadrol is a DHT-derived compound with a 17-alpha alkylated structure that allows oral bioavailability at the cost of significant hepatic strain. In performance enhancement contexts, it is regarded as the single most powerful oral steroid for rapid mass and strength gains, capable of producing dramatic weight increases of 10-15+ pounds in the first few weeks of use. Despite being a DHT derivative that does not aromatize via the aromatase enzyme, Anadrol produces notable estrogenic side effects including water retention and gynecomastia through a poorly understood mechanism believed to involve direct activation of estrogen receptors. This makes estrogen management uniquely challenging compared to other anabolic steroids.

Oxymetholone exerts its effects primarily through binding to the androgen receptor (AR) to promote protein synthesis and nitrogen retention in skeletal muscle. As a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme. However, oxymetholone and its metabolites are believed to directly activate the estrogen receptor, producing estrogenic effects such as water retention and gynecomastia without the involvement of aromatase. This is a critical clinical distinction because aromatase inhibitors (such as anastrozole or letrozole) are ineffective at controlling Anadrol-related estrogenic side effects. The compound also stimulates erythropoietin (EPO) production, significantly increasing red blood cell mass, which is the basis for its FDA-approved indication in anemias. Additionally, oxymetholone inhibits sex hormone-binding globulin (SHBG), increasing the proportion of free testosterone and other anabolic hormones in circulation.

Molecular Data

Research Indications

Anadrol is FDA-approved for the treatment of anemias caused by deficient red cell production. It stimulates erythropoietin production and has been used in patients with bone marrow failure syndromes who are not candidates for transplant.

Prior to the widespread availability of recombinant erythropoietin (EPO), oxymetholone was a primary treatment for renal anemia. It remains a secondary option in resource-limited settings.

Used to support red blood cell production in patients with myelofibrosis and other myeloproliferative disorders causing anemia.

In performance contexts, Anadrol is considered the most effective oral steroid for rapid weight gain. Users commonly report 10-15+ pounds in the first 2-3 weeks, though a significant portion is water and glycogen. Lean tissue gains are substantial when combined with adequate protein intake and training.

Dramatic increases in strength across all compound lifts, often within the first 7-10 days. Anadrol is frequently used as a kickstart compound at the beginning of injectable cycles to provide immediate performance gains while longer-estered injectables reach peak levels.

Oxymetholone has been studied and used off-label for the treatment of weight loss and muscle wasting in HIV-positive patients, showing significant improvements in lean body mass.

Used in clinical settings to combat severe muscle wasting from chronic illness, malnutrition, or prolonged hospitalization.

Dosing Protocols

Anadrol is administered exclusively as an oral tablet. The 17-alpha alkylation allows it to survive first-pass hepatic metabolism and achieve oral bioavailability, but this structural modification is the primary driver of its hepatotoxicity. Tablets are typically available in 25 mg and 50 mg strengths. Due to its short half-life of approximately 8-9 hours, some users split the daily dose into two administrations for more stable blood levels, though single daily dosing is also common.

Conservative / Beginner

25-50 mg/day

Once daily or split into two doses

Oral

Standard Performance Enhancement

50 mg/day

Once daily or split 25 mg twice daily

Advanced / High Dose

100 mg/day

Split into two doses of 50 mg

Medical / Anemia Treatment

1-5 mg/kg/day

Daily

Protocol Variations

Multiple approaches exist - compare before choosing

Different sources recommend different protocols for this peptide. Review each approach and consider your goals, tolerance, and experience level before choosing.

Cycle Kickstart

Source: Common Performance Protocol

"Use Anadrol for the first 4 weeks of a longer injectable cycle to provide immediate mass and strength gains while the injectable testosterone or other compounds reach full saturation."

The most common performance use pattern. Anadrol is added to the first 4 weeks of a 12-16 week injectable cycle (typically testosterone-based). The oral compound delivers rapid size and strength from day one, creating a motivating and productive early phase while the injectable base builds toward peak levels.

Key Points

Immediate results within the first week of the cycle

Transition to injectable-only after week 4 maintains momentum

Total cycle hepatic load is limited by the short oral window

Strength and mass gained during the kickstart phase are largely retained if training and diet remain consistent

Dosing Schedule

Low-Dose Protocol

Source: Conservative Approach

"Maximize the benefit-to-risk ratio by using the lowest effective dose, prioritizing health markers while still achieving meaningful gains."

A growing number of experienced users advocate for 25 mg/day as a sweet spot that provides 70-80% of the results of 50 mg/day with substantially fewer side effects, particularly reduced liver stress, less water retention, and preserved appetite. This approach is especially useful for users who are sensitive to Anadrol's side effects or who want to extend the cycle to 6 weeks.

Significantly reduced liver stress compared to 50-100 mg doses

Less water retention and bloating

Better appetite preservation - a key advantage since appetite suppression limits caloric intake

Can potentially extend cycle duration to 6 weeks with careful liver monitoring

Still produces impressive strength and size gains for most users

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Significant water retention and bloating (estrogenic, not aromatase-mediated)

Elevated blood pressure (fluid volume and RBC increase)

Severe liver stress and elevated liver enzymes (AST/ALT)

Back pumps and lower back pain during exercise

Headaches (often blood pressure-related)

Appetite suppression (paradoxical for a mass-building compound)

Lethargy and fatigue (hepatic strain-related)

Acne and oily skin

Suppression of natural testosterone production

Stop Signs - Discontinue if:

Yellowing of skin or eyes (jaundice - immediate discontinuation required)

Severe persistent right upper quadrant abdominal pain (liver distress)

Dark urine with pale stools (cholestasis)

Severe headaches unresponsive to treatment (potential hypertensive crisis)

Blood in urine or stools

Chest pain or shortness of breath (cardiovascular event or pulmonary embolism)

Rapid or extreme swelling in extremities

Contraindications

Pre-existing liver disease or significantly elevated liver enzymes

Prostate cancer or breast cancer in males

Nephrotic phase of nephritis

Hypercalcemia (Anadrol can exacerbate calcium levels)

Pregnancy (Category X - causes virilization of the female fetus)

Known hypersensitivity to oxymetholone

Concurrent use of other 17-alpha alkylated oral steroids (compounded liver toxicity)

Quality Checklist

Good Signs

Pharmaceutical-grade tablets from a licensed manufacturer (e.g., Anadrol-50 by Unimed/Alaven)

Consistent tablet weight and uniform appearance

Proper packaging with lot number, expiration date, and dosage clearly labeled

Third-party lab testing confirming identity and dosage accuracy

Purchased through a licensed pharmacy with valid prescription

Warning Signs

Underground lab product without pharmaceutical-grade verification

Tablets with inconsistent size, color, or crumbling

Dosage claims above 50 mg per tablet (non-standard for pharmaceutical products)

No third-party testing available

Bad Signs

Tablets with no markings, labeling, or identifiable manufacturer

Product testing reveals incorrect compound or contamination

Capsules instead of pressed tablets (higher risk of inaccurate dosing from UGL sources)

Expired product or product stored in improper conditions

Severe and unexpected side effects suggesting contamination or mislabeling

Frequently Asked Questions

Why don't aromatase inhibitors work well with Anadrol?

Anadrol produces estrogenic effects through direct estrogen receptor activation by the compound or its metabolites, not through aromatization. Aromatase inhibitors block the conversion of testosterone to estrogen, but they don't prevent Anadrol's direct estrogenic activity. SERMs like raloxifene are more effective for managing gynecomastia risk.

How much water weight is typical on Anadrol?

Initial water and glycogen retention accounts for 5-10 lbs of the typical 10-20 lb weight gain in the first 2-3 weeks. This water weight drops quickly after discontinuation (5-10 lbs within 1-2 weeks), though lean tissue gains are largely retained if training and diet remain consistent.

Is Anadrol hepatotoxic compared to other oral steroids?

Yes. The 17-alpha alkylation combined with Anadrol's dose-dependent liver enzyme elevations makes it one of the more hepatotoxic oral steroids. Liver monitoring is essential, cycle duration must not exceed 4-6 weeks maximum, and liver support (TUDCA 500-1000 mg/day) is considered mandatory.

Why is appetite suppression a problem on Anadrol given its mass-building purpose?

Paradoxically, Anadrol often suppresses appetite despite being a mass-builder, particularly at higher doses or as the cycle progresses. This can significantly limit caloric intake just when maximum nutrition is needed for growth, potentially undermining the compound's mass-building potential and forcing dose reduction.

References

Early clinical study demonstrating the efficacy of oxymetholone in stimulating erythropoiesis in patients with aplastic anemia and other refractory anemias, establishing the basis for its FDA approval in hematological indications.

Randomized controlled trial showing that oxymetholone at 100-150 mg/day significantly increased body weight and lean body mass in HIV-positive patients with wasting, with acceptable hepatic safety profiles over the 16-week study period.

Follow-up analysis confirming significant increases in lean body mass and appetite in HIV-positive men treated with oxymetholone, with liver enzyme elevations that returned to baseline after discontinuation.

Characterized the hepatotoxic effects of 17-alpha alkylated steroids including oxymetholone, documenting cholestatic jaundice, peliosis hepatis, and hepatocellular damage with prolonged administration, establishing the rationale for limiting cycle duration.

Comprehensive review of oxymetholone's pharmacology, pharmacokinetics, and clinical applications in anemia treatment. Noted its potent erythropoietic effects and summarized safety data including dose-dependent hepatotoxicity and cardiovascular lipid alterations.

Related Peptides

A testosterone base is considered essential when running Anadrol. Testosterone provides the androgenic foundation that Anadrol lacks (as a DHT derivative that does not convert to estrogen normally), maintains libido and sexual function, and supports overall hormonal balance. Typical concurrent dose is 300-500 mg/week for performance use or TRT dose if running a conservative protocol.

Selective estrogen receptor modulators (SERMs) like raloxifene are the preferred approach for managing gynecomastia risk from Anadrol, since they block the estrogen receptor directly rather than inhibiting aromatase. Raloxifene at 60 mg/day is commonly used to prevent or treat gyno symptoms during Anadrol cycles.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.